No-reflow phenomenon in patients with acute myocardial infarction: Its pathophysiology and clinical implications

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

For patients with acute myocardial infarction (MI), the immediate therapeutic goal is to establish the patency of the infarct-related artery. Prolonged myocardial ischemia, however, often breaks down the coronary microvasculature, and the flow to the infarct myocardium may be markedly reduced. This is called the no-reflow phenomenon. This phenomenon is important not solely because it correlates with infarct size but because it provides additional prognostic information. With recent advances in imaging modalities, the no-reflow phenomenon is observed more frequently than when clinical judgment alone is used. Patients with this phenomenon are associated with poor functional and clinical outcomes. Now, the no-reflow phenomenon can be a parameter with which to predict high-risk patients. The focus of reperfusion therapy has shifted toward the improvement of myocardial perfusion. The improvement of myocardial perfusion could promote the functional recovery of viable muscle and reduce infarct expansion, which is associated with favorable clinical outcomes. For this purpose, pharmacological interventions and catheter-based devices to retrieve embolic materials have been proposed. Advances in our understanding of the pathophysiology of microvascular dysfunction would aid the development of therapeutic strategies for its prevention and treatment.

Original languageEnglish
Pages (from-to)161-168
Number of pages8
JournalActa Medica Okayama
Volume63
Issue number4
Publication statusPublished - Sep 2009

Fingerprint

No-Reflow Phenomenon
Catheters
Muscle
Myocardial Infarction
Imaging techniques
Recovery
Perfusion
Therapeutics
Microvessels
Reperfusion
Myocardial Ischemia
Myocardium
Arteries
Pharmacology
Equipment and Supplies
Muscles

Keywords

  • Cardiac function
  • Coronary intervention
  • Microcirculation
  • Myocardial infarction
  • Reperfusion

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

No-reflow phenomenon in patients with acute myocardial infarction : Its pathophysiology and clinical implications. / Itoh, Hiroshi.

In: Acta Medica Okayama, Vol. 63, No. 4, 09.2009, p. 161-168.

Research output: Contribution to journalArticle

@article{17295697270246999167d524b4ab29b4,
title = "No-reflow phenomenon in patients with acute myocardial infarction: Its pathophysiology and clinical implications",
abstract = "For patients with acute myocardial infarction (MI), the immediate therapeutic goal is to establish the patency of the infarct-related artery. Prolonged myocardial ischemia, however, often breaks down the coronary microvasculature, and the flow to the infarct myocardium may be markedly reduced. This is called the no-reflow phenomenon. This phenomenon is important not solely because it correlates with infarct size but because it provides additional prognostic information. With recent advances in imaging modalities, the no-reflow phenomenon is observed more frequently than when clinical judgment alone is used. Patients with this phenomenon are associated with poor functional and clinical outcomes. Now, the no-reflow phenomenon can be a parameter with which to predict high-risk patients. The focus of reperfusion therapy has shifted toward the improvement of myocardial perfusion. The improvement of myocardial perfusion could promote the functional recovery of viable muscle and reduce infarct expansion, which is associated with favorable clinical outcomes. For this purpose, pharmacological interventions and catheter-based devices to retrieve embolic materials have been proposed. Advances in our understanding of the pathophysiology of microvascular dysfunction would aid the development of therapeutic strategies for its prevention and treatment.",
keywords = "Cardiac function, Coronary intervention, Microcirculation, Myocardial infarction, Reperfusion",
author = "Hiroshi Itoh",
year = "2009",
month = "9",
language = "English",
volume = "63",
pages = "161--168",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "4",

}

TY - JOUR

T1 - No-reflow phenomenon in patients with acute myocardial infarction

T2 - Its pathophysiology and clinical implications

AU - Itoh, Hiroshi

PY - 2009/9

Y1 - 2009/9

N2 - For patients with acute myocardial infarction (MI), the immediate therapeutic goal is to establish the patency of the infarct-related artery. Prolonged myocardial ischemia, however, often breaks down the coronary microvasculature, and the flow to the infarct myocardium may be markedly reduced. This is called the no-reflow phenomenon. This phenomenon is important not solely because it correlates with infarct size but because it provides additional prognostic information. With recent advances in imaging modalities, the no-reflow phenomenon is observed more frequently than when clinical judgment alone is used. Patients with this phenomenon are associated with poor functional and clinical outcomes. Now, the no-reflow phenomenon can be a parameter with which to predict high-risk patients. The focus of reperfusion therapy has shifted toward the improvement of myocardial perfusion. The improvement of myocardial perfusion could promote the functional recovery of viable muscle and reduce infarct expansion, which is associated with favorable clinical outcomes. For this purpose, pharmacological interventions and catheter-based devices to retrieve embolic materials have been proposed. Advances in our understanding of the pathophysiology of microvascular dysfunction would aid the development of therapeutic strategies for its prevention and treatment.

AB - For patients with acute myocardial infarction (MI), the immediate therapeutic goal is to establish the patency of the infarct-related artery. Prolonged myocardial ischemia, however, often breaks down the coronary microvasculature, and the flow to the infarct myocardium may be markedly reduced. This is called the no-reflow phenomenon. This phenomenon is important not solely because it correlates with infarct size but because it provides additional prognostic information. With recent advances in imaging modalities, the no-reflow phenomenon is observed more frequently than when clinical judgment alone is used. Patients with this phenomenon are associated with poor functional and clinical outcomes. Now, the no-reflow phenomenon can be a parameter with which to predict high-risk patients. The focus of reperfusion therapy has shifted toward the improvement of myocardial perfusion. The improvement of myocardial perfusion could promote the functional recovery of viable muscle and reduce infarct expansion, which is associated with favorable clinical outcomes. For this purpose, pharmacological interventions and catheter-based devices to retrieve embolic materials have been proposed. Advances in our understanding of the pathophysiology of microvascular dysfunction would aid the development of therapeutic strategies for its prevention and treatment.

KW - Cardiac function

KW - Coronary intervention

KW - Microcirculation

KW - Myocardial infarction

KW - Reperfusion

UR - http://www.scopus.com/inward/record.url?scp=70349332662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349332662&partnerID=8YFLogxK

M3 - Article

C2 - 19727200

AN - SCOPUS:70349332662

VL - 63

SP - 161

EP - 168

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 4

ER -